Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C23H33NO2 |
| Molecular Weight | 355.5136 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)C1=CC(CCCOCC2=CN=CC=C2)=CC(=C1O)C(C)(C)C
InChI
InChIKey=YNBBIPPQHYZTQF-UHFFFAOYSA-N
InChI=1S/C23H33NO2/c1-22(2,3)19-13-17(14-20(21(19)25)23(4,5)6)10-8-12-26-16-18-9-7-11-24-15-18/h7,9,11,13-15,25H,8,10,12,16H2,1-6H3
| Molecular Formula | C23H33NO2 |
| Molecular Weight | 355.5136 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://adisinsight.springer.com/drugs/800004102
Sources: https://adisinsight.springer.com/drugs/800004102
Nicanartine [MRZ 3124] is an antioxidant and cholesterol-lowering agent that was under development with Merz + Co. (later Merz Pharma) in Germany. Development of nicanartine for the treatment of atherosclerosis and reperfusion injury was discontinued at the phase I stage.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| [Study of lipid peroxidation inhibition in human blood by several endogenous and exogenous compounds]. | 2000-10 |
|
| Chain-breaking antioxidants and ferriheme-bound drugs are synergistic inhibitors of erythrocyte membrane peroxidation. | 1998-02 |
|
| Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty. | 1998 |
|
| Effects of the new antioxidant nicanartine in an experimental model of atherosclerosis. | 1996-10 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9222640
In order to study the contribution of oxidant stress to the pathogenesis of experimental diabetic retinopathy, male streptozotocin diabetic Lewis rats were treated nicanartine (80 mg/kg) by oral supplementation for 6 months
Route of Administration:
Oral
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/9784030
Nicanartine concentration dependently reduced LPO and H2O2 production already at a concentration of 1 uM, whereas LC and LM amplified CL and WB-CL were not affected. EROD and END were concentration dependently diminished starting at 1 uM, and ECOD already at 0.1 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:28:31 GMT 2025
by
admin
on
Mon Mar 31 18:28:31 GMT 2025
|
| Record UNII |
85DV2PAF78
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29703
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
||
|
NCI_THESAURUS |
C275
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
85DV2PAF78
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
DTXSID20164552
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
150443-71-3
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
SUB09223MIG
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
100000084166
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
7241
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104882
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
C100546
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
C75298
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY | |||
|
66001
Created by
admin on Mon Mar 31 18:28:31 GMT 2025 , Edited by admin on Mon Mar 31 18:28:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |